A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Clinical trial NCT01067859 · TERMINATED
Trial details
- NCT number
- NCT01067859
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.